Alphabet »

Bridgebio Oncology Therapeut shares owned by Alphabet

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Alphabet from 13F filings

Historical chart of Alphabet investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Alphabet consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Alphabet

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 2.8M 11.58

More positions owned by Alphabet

Ast Spacemobile Com Cl A (ASTS)
Planet Labs Pbc Com Cl A (PL)
Arm Holdings Sponsored Ads (ARM)
Mestera (MTSR)
Revolution Medicines (RVMD)
Freshworks Class A Com (FRSH)
Tempus Ai Cl A (TEM)
Gitlab Class A Com (GTLB)
Uipath Cl A (PATH)
Prime Medicine (PRME)
Dex (DXCM)
Maze Therapeatics (MAZE)
Bridgebio Oncology Therapeut Com New
Figma Class A Com Stk (FIG)
Monte Rosa Therapeutics (GLUE)

View all positions for Alphabet

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut